Show channels:
All channels
Bladder cancer
Brain and spinal
Breast cancer
Cervical
Colon & rectal
Dermatological
General Information
Gynecological
Head and Neck
Kidney/adrenal
Liver
Lung
Lymphoma
Multiple Myeloma
Myelodysplastic syndromes
Myeloproliferative disorders
Pancreas
Pediatric
Prostate
Sarcoma
Stomach
Testicular
Thyroid
Upper aerodigestive
Found 15774 articles
ASB2 is a direct target of FLI1 that sustains NF-κB pathway activation in germinal center-derived diffuse large B-cell lymphoma
FLI1 gene more frequently expressed at higher levels in GCB than in ABC DLBCL.
»
11/11/21
Impact of the line of treatment on progression-free survival in patients treated with T-DM1 for metastatic breast cancer
No significant difference in PFS whether or not patients had received prior treatment with capecitabine/lapatinib.
»
11/11/21
ROR1 and ROR2 expression in pancreatic cancer
High ROR1 mRNA expression levels correlated with favorable OS outcome.
»
11/11/21
Hexokinases 2 promoted cell motility and distant metastasis by elevating fibronectin through Akt1/p-Akt1 in cervical cancer cells
HK2 expression altered with changing of Akt1/p-Akt1 expression.
»
11/10/21
Prognostic value of immune factors in the tumor microenvironment of patients with pancreatic ductal adenocarcinoma
PDAC TME with high density of TILs/high PD-1 positivity/low Foxp3 expression independent predictive marker associated with superior prognosis.
»
11/10/21
Focal adhesion kinase inhibitor TAE226 combined with Sorafenib slows down hepatocellular carcinoma by multiple epigenetic effects
TAE226 more effective FAKi to be combined with SOR against HCC.
»
11/16/21
Prediction of survival after eribulin chemotherapy for breast cancer by absolute lymphocyte counts and progression types
PPL group had significantly better prognosis than PNM group.
»
11/15/21
Alternative splicing of NF-YA promotes prostate cancer aggressiveness and represents a new molecular marker for clinical stratification of patients
Elevated NF-YAs levels associated to aggressive PCa specimens.
»
11/15/21
Circular RNA circHERC4 as a novel oncogenic driver to promote tumor metastasis via the miR-556-5p/CTBP2/E-cadherin axis in colorectal cancer
CircHERC4 inactivated tumor suppressor, miR-556-5p.
»
11/15/21
Prediction of anti-CD25 and 5-FU treatments efficacy for pancreatic cancer using a mathematical model
Rational approach to therapy optimization with meaningful consequences.
»
11/15/21
< Prev
Next >